All posts by imreal

Technology: Computer

Energybox Welcomes New Board Member

Leave a comment

[ad_1]

With Energybox’s analytics and automation capabilities, the company is constantly finding opportunities for additional energy savings and the market is noticing.


NASHVILLE, Tenn. (PRWEB)

Energybox is pleased to announce the appointment of our new Board Member, Karl Meyer. His deep expertise in driving revenue at high-growth companies brings a wealth of experience that will position Energybox well to reach new heights. Specifically, Karl has an exceptional operational background that will drive Energybox’s expansion at its current Global 2,000 customers as well as land new enterprise customers. The management team and board are very excited and are looking forward to working with Karl on delivering Energybox’s vision.

Karl is the Managing Director and Head of Global Portfolio Operations at Digital Alpha, a leading investment firm focused on digital infrastructure. The three investment focus areas for Digital Alpha include Next Generation Networks, Cloud, and IoT / Smart Cities. Digital Alpha invested in Energybox because of its holistic energy management solution that includes fully integrated IoT hardware, sensors, and cloud-based analytics software that reduces energy units for a wide range of customers. Some of the core use cases are targeted at multi-site retail chains that tend to consume large amounts of energy.

“In our quest to become the market leader for IoT monitoring and automation solutions for multi-site enterprises, we are very excited to welcome Karl Meyer to our Board of Directors,” said Nicolai Wiest, CEO of Energybox. “With the latest trends and needs towards solving environmental as well as operational and labor issues, the opportunities for automation and sustainability are huge. We are looking forward to working closely with Karl, building strategic partnerships, expanding our business in key industry verticals and continuing to provide exceptional value and benefits to our customers.”

“I’m thrilled to be a member of Energybox’s board and to be working with a highly experienced management team,” said Karl Meyer, Managing Director at Digital Alpha. “I love Energybox’s story because the simplest way to reduce cost and carbon footprint is through reduced energy usage. Energybox’s solution makes a typical 10%-20% energy usage reduction painless for the customer. In addition, with Energybox’s analytics and automation capabilities, the company is constantly finding opportunities for additional energy savings and the market is noticing. I’m pleased to be joining the company at this inflection point in the market, where measuring energy efficiency is vital for businesses embracing ESG (environmental, social, governance) principles worldwide.”

About Energybox

Energybox is a leading IoT automation company. We help multi-site customers automate their operations, reduce costs and improve sustainability. Our portfolio of fully integrated IoT solutions includes proprietary sensors, controls, software and AI. We sell our Solutions as a Service with immediate customer benefits and savings. We serve a wide range of multi-site customers including convenience stores, laboratories, quick-serve restaurants, and grocery stores. For more information, please visit http://www.energybox.com

About Digital Alpha

Digital Alpha Advisors, LLC is an investment firm focused on digital infrastructure and services required by the digital economy with total assets under management of over $1.5B. The firm has a strategic collaboration agreement with Cisco Systems, Inc. As part of this agreement, Digital Alpha has preferred access to Cisco’s pipeline of commercial opportunities requiring equity financing. In addition, Digital Alpha has cultivated strategic partnerships with other Silicon Valley technology leaders, with whom it has already executed deals. Digital Alpha believes that it is the first firm focused on making private equity investments in the significant growth opportunities required to underpin the Digital Economy, including smart cities, next generation broadband networks, and enterprise data management and communication solutions. Digital Alpha was founded in 2017 by Rick Shrotri, former Head of the Global Infrastructure Funds (GIF) team at Cisco, and closed its latest Fund – Digital Alpha Fund II, LP – in early 2021. For more information, please visit http://www.digitalalpha.net.

Share article on social media or email:

[ad_2]

Health

American Homecare Health Services Names Marilyn “Rena” Taylor-Duncan Director of Patient Care Services

Leave a comment

[ad_1]

Marilyn “Rena” Taylor-Duncan

“As the new DPCS at American Homecare, my mission will be to support our staff and to provide the best possible care to improve our patients’ experience and quality of life,” says Taylor-Duncan.


LOS ANGELES (PRWEB)

American Homecare Health Services (AHHS), a Los-Angeles based home healthcare agency, announced today that Marilyn “Rena” Taylor-Duncan was selected to be its’ new Director of Patient Care Services (DPCS). Taylor-Duncan was most recently the DPCS at Saint Joseph Health System Home Health Agency.

With over 20 years’ experience within healthcare services, home health, health insurance, regulatory compliance and quality sectors, Taylor-Duncan excels at management skills with the ability to lead and motivate people while delivering results for the companies she has worked for.

“As the new DPCS at American Homecare, my mission will be to support our staff and to provide the best possible care to improve our patients’ experience and quality of life,” says Taylor-Duncan.

She continues, “AHHS recently achieved a 4-star CMS rating. This is a clear indication to the community that we provide a high level of care and patient satisfaction. I will work hard to promote our care and continue building confidence in our service.”

At AHHS, Taylor-Duncan will oversee patient admissions, patient and family interactions, leading, directing and supervising staff, ensuring compliance and quality care, and establishing and maintaining community relations and outreach.

About American Homecare Health Services:

AHHS was established in 2000 with one goal in mind: to serve the community by providing quality healthcare for those in need. AHHS is accredited by the Joint Commission, Medicare/Medical certified, a preferred provider to Blue Cross and Blue Shield, contracted by Kaiser and a provider of services for IPA’s such as Lakeside/Regal Medical Group and Facey Medical Group. AHHS provides Skilled Nursing Care, Home Health Aides, Occupational Therapy, Physical Therapy, Speech Therapy, Medical Social Services, Dieticians, Home Intravenous (IV) Services and Hospice Care Services. For more information call: 818-566-1020.

Share article on social media or email:

[ad_2]

Health

Specific Diagnostics Announces First French Tender Award and LIS Connectivity

Leave a comment

[ad_1]

Specific Reveal Rapid AST System

Specific Reveal Rapid AST System

“Last year we completed several performance studies with Reveal Rapid AST in France, but our goal was always focused on improving patient care and reducing antibiotic resistance,” said Mr. Scott O’Brien, Chief Commercial Officer of Specific.


SAN JOSE, Calif. (PRWEB)

Specific Diagnostics today announced its first French tender award for the Reveal Rapid AST Blood Culture Gram-Negative Sensor Panel. Following the completion of several Reveal Rapid AST performance studies in France, several of these sites are now progressing to clinical use.

“A group of our early adopter sites are working together to generate clinical impact data driven by rapid AST. These interventional studies will directly measure the impact of antibiotic escalation and de-escalation on patient care while also gauging the impact on antimicrobial stewardship and dosing regimens,” said Mr. Scott O’Brien, Chief Commercial Officer of Specific.

“Last year we completed several performance studies with Reveal Rapid AST in France, but our goal was always focused on improving patient care and reducing antibiotic resistance. Our France team has just achieved this first milestone toward our vision of improving the lives of patients,” added O’Brien.

Related to commercial activity in France, Specific has also completed its first successful bi-directional connection of the Reveal system to GLIMS, the most widely used LIS in Europe1. “From the early stages of development we knew data management and instrument connectivity in the hospital are a critical requirement for realizing lab efficiency and optimal patient benefit. As a result, we designed the Reveal system and software with functionality and flexibility for broad LIS connectivity,” said Elias Fayad, VP Software Engineering.

For more information and the opportunity to receive a demonstration of the Reveal Rapid AST system, Specific Diagnostics will be attending the upcoming Institute of BioMedical Science Congress in Birmingham, UK and the 32nd European Congress of Clinical Microbiology & Infectious Diseases in Lisbon, Portugal.

About Specific

Specific Diagnostics has developed in vitro diagnostic systems based upon a unique, patented metabolomic signature technology that enables rapid detection and identification of microorganisms as they grow in culture. Its first commercial application applies this fundamental new platform to the rapid determination of antimicrobial susceptibility directly from positive blood cultures, as well as isolate dilutions. Specific is based in San Jose, CA, with subsidiaries in Ireland, France and the UK.

For press inquiries, please contact: press@specificdx.com

1.    https://www.clinisysgroup.com/in/en/solution/glims/

Share article on social media or email:

[ad_2]

Health

Senzo Education Poll confirms the need for new, better rapid tests for COVID-19

Leave a comment

[ad_1]

“This poll provides further evidence of the need for better rapid testing to get the world back to normal, and Senzo is poised to deliver our ALF COVID-19 test to achieve this,” says Senzo CEO Jeremy Stackawitz.


PHILADELPHIA (PRWEB)

A new survey conducted on behalf of Senzo, a leading in vitro diagnostics company, reports that approximately one third (28%) of educators have received false results from rapid COVID-19 tests in the past, and more than two thirds (83%) of respondents indicated that more accurate tests would increase their confidence in physically attending school, suggesting a strong need for better rapid COVID-19 tests.

As the developer of a breakthrough Amplified Lateral Flow (ALF) Test for COVID-19 with 10,000 times better sensitivity than existing tests, Senzo conducted this poll to gain insight into the opinions of educators, who due to the nature of their work, are often at a high risk of exposure to the virus.

The poll, conducted online in January 2022 among a group of 100 US and UK adults ages 18 and older who are actively employed in the education sector, also found that 70% believe that accurate rapid testing is very important and 66% think a more accurate rapid test would be very beneficial. These results continue to substantiate the importance of Senzo’s mission to bring a better rapid-testing COVID-19 product to market.

“This poll provides further evidence of the need for better rapid testing to get the world back to normal, and Senzo is poised to deliver our ALF COVID-19 test to achieve this,” added Senzo CEO, Jeremy Stackawitz.

The survey produced notable results, broken down into the following categories:


  • Experience with misleading test results – Nearly one-third (28%) of respondents reported getting either a false positive or false negative result from a rapid test for COVID-19 at least once in the past. This further confirms Senzo’s stance that current rapid testing is not where it should be in terms of accuracy.

  • Testing accuracy importance to prevent the spread of COVID-19 – Senzo’s poll also shows that 70% of respondents feel that accurate COVID-19 testing is “very important” in preventing the spread of COVID-19.

  • Testing accuracy in relation to educator confidence – Senzo’s poll shows that 83% of adults employed in education would feel more confident attending school with their students and coworkers, or attending social gatherings, if they had access to more accurate testing. More than half of those surveyed (44%) said it would make them “much more confident,” while 39% said it would make them “moderately more confident.”

  • Overall benefit of more accurate testing – When asked how beneficial overall they think a more accurate rapid COVID test would be for educators and students, the clear majority (66%) said it would be “very beneficial,” while 28% admitted it would at least be “moderately beneficial.” Only 8% of respondents said it “would not make a significant difference.”

Accurate, rapid testing is key to the safety of teachers, students, and other school faculty members, but Senzo finds that current lateral flow tests are not sufficiently accurate (only 57.5% accurate according to independent evaluations conducted by UK NHS Test and Trace professionals), and PCR tests can take days to get results. Senzo’s ALF, soon to be widely available, solves these problems by combining the speed, affordability, and simplicity of a 7-minute lateral flow rapid antigen home-test with the accuracy of professional PCR technology.

About: Senzo is an in vitro diagnostics company developing innovative, accurate, and accessible testing products. Senzo was founded with the vision of utilizing novel technologies, with a focus on enhanced sensitivity, to create mobile, point-of-care products and devices with the ability to accurately, quickly, and cost-effectively conduct testing where healthcare professionals and patients need it most. Senzo is creating game-changing products and systems which bring testing to the patient, eliminating the need for the current slow, expensive central-lab testing paradigms. With insights generated at the point of care, patients can make better decisions faster, and healthcare professionals can identify life-threatening diseases at an earlier stage, improving treatment outcomes and saving lives.

For more information, visit https://www.senzo.com/.

Share article on social media or email:

[ad_2]

Health

Mytonomy Announces Cardiology Content and Platform That Meets Patients Wherever They Are & New Partnership with MedAxiom

Leave a comment

[ad_1]

“By educating patients before, during and after the visit, providers can save staff time while reducing patient anxiety and improving cardiac outcomes,” said Anjali Kataria, Mytonomy CEO and co-founder.


BETHESDA, Md. (PRWEB)

Mytonomy, known for raising the bar in video-based patient-engagement content and platform, is leveraging its capabilities in the cardiology space with its new Cloud for Cardiology. Featuring the most comprehensive catalog of cardiology videos in the industry, Cloud for Cardiology unpacks procedures and cardiac conditions in a patient-friendly format, while serving provider’s needs as well.

The entire 700+ title microlearning video library can easily be accessed through Mytonomy’s platform, which integrates seamlessly with a provider’s existing clinical workflows. Mytonomy delivers intelligent nudging, notifications and messages to activate patients throughout their care journey and support post discharge Remote Patient Monitoring programs, like those for heart failure and other conditions.

Topics available are related to commonly performed diagnostic testing as well as surgical and interventional cardiac therapies. This is paired with an extensive review of cardiometabolic conditions including diabetes, hypertension and hyperlipidemia. Microlearning videos are designed to deliver essential information to patients in an appealing format, short enough to encourage patients to watch all the way through.

Developed in partnership with leading heart centers, each Mytonomy microlearning video is essentially an extension of the patient’s care team, answering questions and addressing concerns, without increasing clinicians’ workloads. Mytonomy drives improvement in clinical outcomes and patient experience. Multiple validated studies across major medical conditions including cardiac care have demonstrated high engagement, better results, and increased patient satisfaction. A multi-site study conducted across three major academic centers also showed improved results in cardiovascular risk factors.

“Mytonomy provided exceptional content on hypertension and hyperlipidemia for our cardiovascular remote health program,” says Dr. Christopher Cannon, Education Director of Cardiovascular Innovation at Brigham & Women’s Hospital in Boston. “In addition, we are very impressed by the development process for new medical videos that we developed together. Our patients responded positively to the video content that helped them work on their cardiac health.”

Along with patient education, Cloud for Cardiology features cardiac-related surveys that can be deployed through patient portals or sent directly to patients via email or SMS. Patients can take quality of life surveys, learn the purpose of the surveys and results are recorded in their chart. Survey data can be analyzed individually or in aggregate.

Mytonomy’s commitment to cardiology is evidenced by its partnership with MedAxiom, the cardiovascular community’s premier source for organizational performance solutions. “Mytonomy’s mission is to educate and empower people to actively engage in their health,” said Joe Sasson PhD, MedAxiom’s EVP of Ventures. “With their solutions, providers can save valuable time while improving patient outcomes. We are proud to welcome Mytonomy as a MedAxiom Industry Partner and bring their deep cardiovascular solutions to our membership community.”

“Mytonomy’s novel CRM is an essential part of a healthcare system’s digital front door strategy for cardiac care. By educating patients before, during and after the visit, providers can save staff time while reducing patient anxiety and improving cardiac outcomes,” said Anjali Kataria, Mytonomy CEO and co-founder. “Our partnership with MedAxiom will open up more ways the cardiovascular community can engage patients throughout their care journey.”

Mytonomy is an industry leader in applying the science of microlearning to medical education videos. Mytonomy’s internal medical team ensures that content is accurate, credible and vetted by leading subject matter experts in multidisciplinary cardiac care. Keeping production values high — peer reviewed scripts, compelling graphics, and relatable on-camera talent — makes sure patients are not merely engaged; they’re entertained and empowered to partner in their own health.

MYTONOMY

Mytonomy Inc., based in Bethesda, MD is a novel CRM and a leader in enterprise cloud solutions for video-based patient engagement and education. An essential part of a healthcare systems’ digital front door, Mytonomy creates efficiencies for doctors and nurses by streaming broadcast-quality microlearning videos and delivering integrated communications to patients that adapt to each patient so that they can lead healthier, happier lives.

Mytonomy’s Cloud for Healthcare is integrated with intelligent nudging to activate patients throughout their care journey and enables clinicians to combat misinformation and enhance quality of care. Mytonomy has multiple validated studies achieved across major medical conditions demonstrating better results.

Mytonomy’s Cloud for Healthcare is fully interoperable with all major EMRs and CRM solutions, covering 100+ conditions with over 2000 episodes that can be rapidly customized to each hospital, all delivered via a single engagement platform. Moving healthcare from the exam room to the living room is made easy with Mytonomy’s first TV channel on the Roku® platform.

Mytonomy is listed #835 on the 2021 Inc. 5000 list of fastest growing companies in the US and has won numerous recognitions for being best-in-class in patient engagement software and patient education content. Moving healthcare from the exam room to the living room is made easy with Mytonomy’s first TV channel on the Roku® platform. To learn more about Mytonomy, please visit http://www.mytonomy.com.

Share article on social media or email:

[ad_2]

Health

Local Non-Profit Partners with Rock Legend to Fight Rare Disease

Leave a comment

[ad_1]

“Inclusion Body Myositis and other rare diseases affect more than 350 million people globally, yet we still know so little about many of these diseases,” said Grammy Award winning artist Peter Frampton.


CHICAGO (PRWEB)

Harmony 4 Hope, a non-profit organization merging music and storytelling to provide funding for the research of rare diseases, is teaming up with Grammy Award winner and NYT Best Selling Author Peter Frampton to raise awareness for rare disease.

Together with the Genomic Sciences and Precision Medicine Center at the Medical College of Wisconsin, Children’s Hospital of Wisconsin, Johns Hopkins Medicine, and sponsor Horizon Therapeutics, Harmony 4 Hope is proud to welcome Peter Frampton as a guest at their upcoming Rare Storytellers event as he shares his story of living with Inclusion Body Myositis and his diagnostic journey.

“We could not be more pleased to welcome Peter Frampton as a Rare Storyteller,” said Kerry Hughes, Executive Director of Harmony 4 Hope. “Rare Storytellers is a rapidly growing network of patients, musicians and medical professionals currently representing over 30 rare diseases. Adding a strong voice like Peter Frampton’s shows just how impactful these diseases are, and how critical the research being done to cure them is.”

Peter Frampton, one of the most celebrated artists in rock history, was diagnosed with Inclusion Body Myositis (IBM), a rare autoimmune disease, in 2015. Following his diagnosis, Frampton partnered with Johns Hopkins, the facility where he is currently being treated, to create The Peter Frampton Myositis Research Fund at Johns Hopkins. The Fund is dedicated to improving the lives of more than 24,000 patients currently living with IBM and to, ultimately, find a cure.

“Inclusion Body Myositis and other rare diseases affect more than 350 million people globally, yet we still know so little about many of these diseases,” said Grammy Award winning artist Peter Frampton. “Where there is education, there is a greater chance for funding and advancing research.”

Held annually on the last day of February, World Rare Disease Day offers people across the globe a chance to come together to celebrate and recognize the over 7,000 Rare Diseases that collectively impact over 350,000,000 around the world. Rare Storytellers, a division of Harmony 4 Hope created for the purpose of educating on Rare Diseases through songs, stories and science, is taking measures to ensure this year’s celebration is extra special.

In addition to a featured discussion between Kerry Hughes and Peter Frampton, this year’s event will feature Dr. Lisa Christopher-Stine, associate professor at John Hopkins School of Medicine and Peter Frampton’s physician, to share more about IBM and its impact on those affected by the disease.

The musical performance for this event will be given by H4H Musical Ambassador, Peter Dankelson. Peter was diagnosed with Goldenhar Syndrome, also known as Oculo-Auriculo-Vertebral Syndrome (OAVS) at a young age. Peter is a musician and motivational speaker for Pete’s Diary and just published his autobiography, How I Learned to Rock My Life in January 2022.

This year’s event “Rare Storytellers: Meet Peter Frampton” will be hosted on March 15, 2022 at 2:00 p.m. CT. Registration for the event is open and available to the public here.

For more information on Harmony 4 Hope, Rare Storytellers, or how you can get involved in this year’s celebration of World Rare Disease Day, please visit http://www.harmony4hope.org or contact Kerry Hughes at kerry.hughes@harmony4hope.org.

###

Harmony 4 Hope

Harmony 4 Hope (H4H) is a non-profit organization merging music and storytelling to provide funding for research, increase awareness of rare diseases, uplift patients and families through music and ultimately improve the lives of the 350 million individuals worldwide collectively impacted by more than 7,000 rare diseases. Through music centered fundraisers and corporate sponsored Rare Storytellers, H4H provides grants to external research entities annually. Learn more at http://www.harmony4hope.org.

Share article on social media or email:

[ad_2]

Health

AdventHealth Ocala receives $1.7 million donation to launch Maternal Fetal Medicine program

Leave a comment

[ad_1]

Michael and Kathleen Smith present AdventHealth Ocala leaders and the Gray family with a check to launch the Maternal Fetal Medicine program.

“This incredible showing of generosity from Michael Smith and his family supports us in our promise to continuously elevate the care of our community and serve families in a way they’ve never experienced before,” said AdventHealth Ocala President and CEO Joe Johnson.


OCALA, Fla. (PRWEB)

AdventHealth Ocala is pleased to announce the introduction of the McKenzie Kearney Gray Maternal Fetal Medicine (MFM) program to elevate the pre- and post-natal care of high-risk pregnancy patients close to home. Currently, families must travel miles outside of Marion County to receive this highly specialized pregnancy related care. This program will allow families to remain in the AdventHealth system and receive world class care from nationally ranked AdventHealth for Women and AdventHealth for Children specialists, with expertise in the care of women with multiple high-risk pregnancy factors and babies who are born after high-risk pregnancies.

“As Marion County’s only obstetrics and neonatal intensive care unit, we are committed to investing in the programs, technology and teams to help us positively impact families for years to come,” said Joe Johnson, President and CEO, AdventHealth Ocala. “This incredible showing of generosity from Michael Smith and his family supports us in our promise to continuously elevate the care of our community and serve families in a way they’ve never experienced before.”

Maternal Fetal Medicine care teams work with the obstetrician and help guide practices to achieve the best possible outcome for complicated pregnancies. They identify risk factors during pregnancy such as the delivery of multiples, and other complicated risk factors such as maternal hypertension, diabetes, fetuses with birth defects and genetic issues to assist families in making the best plans for a safe delivery.

“We are excited to bring this program to Marion County through our partnership with AdventHealth Ocala. This will complement the specialized neonatology services that are already in place at AdventHealth Ocala’s level 2 NICU, staffed by board certified Neonatologists and specially trained Neonatal Nurse Practitioners,” said Rajan Wadhawan, MD, MMM, Senior Executive Officer for AdventHealth for Children and AdventHealth for Women. “Our program in Ocala will be a part of the extensive network of AdventHealth for Women and AdventHealth for Children in Orlando. This will allow us to bring the same high level of expertise to Marion County that is only available in bigger centers today.”

The MFM program at AdventHealth Ocala was funded in part by local philanthropists Michael and Kathleen Smith through a generous donation of $1.7 million to the AdventHealth Ocala Foundation in honor of McKenzie Kearney Gray, daughter of Ryan and Kait Gray, of Ocala. McKenzie was born premature and passed away days later.

“Since coming to Ocala my wife, Kathleen, and I have been moved by Ryan and Kait’s story,” said Michael Smith. “The past few years, we have honored McKenzie by contributing to the McKenzie’s Moment charitable organization. We were looking for opportunities to impact the lives of expecting parents in Marion County and we are privileged to participate in the establishment of AdventHealth Ocala’s Maternal Fetal Medicine program. Ocala is a special place, and this gift expresses our love and gratitude.”

The MFM program at AdventHealth Ocala will build on the health system’s robust network of neonatal and pediatric care services in Marion County. AdventHealth Ocala is home to world-class neonatal and pediatric services where nationally ranked AdventHealth for Children physicians care for the smallest patients. The hospital houses a Level II neonatal intensive care unit (NICU) which is staffed 24 hours a day with specialized neonatal care nurses and neonatologists. Additionally, AdventHealth Ocala has the area’s only pediatric cardiologist specializing in fetal echocardiograms for high-risk pregnancies in Marion County through AdventHealth for Children.

The program will officially start Fall 2022.

About AdventHealth Ocala

AdventHealth Ocala is a 385-bed full-service community hospital that opened in 1898. In August 2018, AdventHealth Ocala became a part of the AdventHealth network. The facility is 640,000 square feet and sits on 15-acres. Within the hospital network there are two 24/7 ER facilities, one onsite and another offsite, to better meet the needs of Marion County. The onsite ER has both an adult and children’s emergency department that has over 50 combined beds with the ability to treat many conditions and injuries. Established in 2002, the offsite ER, AdventHealth TimberRidge ER, is a 24-hour full-service emergency department with 16 private rooms and was the first offsite ER in the state of Florida. The hospital offers many inpatient services including, labor and delivery through The Baby Place®, Orthopedic unit, comprehensive cardiovascular surgery unit, and a wound care center. AdventHealth Ocala is accredited The Joint Commission and has received recognition from American Heart Association and American Stroke Association. They are accredited by the American College of Cardiology in Chest Pain, Heart Failure, Cardiac Cath Lab, Electrophysiology, Transcatheter Valve Certified and awarded the HeartCARE™ Center designation. They are also a Certified Advanced Primary Stroke Center as well as a Center of Excellence in Robotic Surgery.

About AdventHealth Ocala Foundation

The AdventHealth Ocala Foundation is a not-for-profit 501c3 that supports programs and services throughout AdventHealth Ocala. Through generous donations and acts of gratitude, our Foundation funds new facilities, and life-saving equipment and technology to advance medicine, enhance patient experiences and provide world-class health care, close to home. With a sacred mission of Extending the Healing Ministry of Christ, our Foundation strives to help more people feel whole and live their healthiest life possible. For more information, please visit AdventHealthFoundationWestFL.com.

Share article on social media or email:

[ad_2]

Science: Biology

Yousef Benhamida accepted into Forbes Business Council

Leave a comment

[ad_1]

Yousef Benhamida

Yousef Benhamida

You are and become who you hang around with most often. I am grateful to be accepted into the Forbes Council organization and look forward to being around more people who are successful leaders in business.


SAN DIEGO (PRWEB)

Founder and Chief Executive Officer Yousef Benhamida of HS Supplies, one of the major plant nutrient manufacturers and suppliers to hydroponic and agricultural distributors in the United States, has been accepted into the Forbes Business Council, the foremost growth and networking organization for successful business owners and leaders worldwide.

Yousef was vetted and selected by a review committee based on the depth and diversity of his experience. Criteria for acceptance include a track record of successfully impacting business growth metrics, as well as personal and professional achievements and honors.

“We are honored to welcome Yousef into the community,” said Scott Gerber, founder of Forbes Councils, the collective that includes Forbes Business Council. “Our mission with Forbes Councils is to bring together proven leaders from every industry, creating a curated, social capital-driven network that helps every member grow professionally and make an even greater impact on the business world.”

As an accepted member of the Council, Yousef has access to a variety of exclusive opportunities designed to help him reach peak professional influence. He will connect and collaborate with other respected local leaders in a private forum and at members-only events. Yousef will also be invited to work with a professional editorial team to share his expert insights in original business articles on Forbes.com, and to contribute to published Q&A panels alongside other experts.

Finally, Yousef will benefit from exclusive access to vetted business service partners, membership-branded marketing collateral, and the high-touch support of the Forbes Councils member concierge team.

ABOUT FORBES COUNCILS

Forbes Councils is a collective of invitation-only communities created in partnership with Forbes and the expert community builders who founded Young Entrepreneur Council (YEC). In Forbes Councils, exceptional business owners and leaders come together with the people and resources that can help them thrive.

To learn more about Forbes Councils, visit forbescouncils.com.

Share article on social media or email:

[ad_2]

Technology: Computer

The Top Board Management Software Vendors According to the FeaturedCustomers Winter 2022 Customer Success Report Rankings

Leave a comment

[ad_1]

News Image


SUNRISE, Fla. (PRWEB)

Today FeaturedCustomers published the Winter 2022 Board Management Software Customer Success Report to give prospects better insight on which Board Management Software would work best for their business according to real customer references.

The highest rated vendors according to the Winter 2022 Board Management Software Customer Success Report are:

Market Leaders – Board Intelligence, BoardDocs, Convene, Diligent, Govenda, OnBoard, and Pervasent were given the highest “Market Leader” award. Market Leaders are vendors with a substantial customer base & market share. Market Leaders have the highest ratio of customer reference content, content quality score, and social media presence relative to company size.

Top Performers – Aprio, Boardable, BoardEffect, BoardPAC, eShare, iDeals, and Sherpany were awarded “Top Performer” honors. Top Performers are vendors with significant market presence and enough customer reference content to validate their vision. Top Performers products are highly rated by its customers but have not achieved the customer base and scale of a Market Leader relative to company size.

Rising Stars – BoardPaq, BoardPro, DiliTrust, and Simbli were awarded the “Rising Star” honor. Rising Stars are vendors that do not have the market presence of Market Leaders or Top Performers but understand where the market is going and has disruptive technology. Rising Stars have been around long enough to establish momentum and a minimum amount of customer reference content along with a growing social presence.

About the Board Management Software Customer Success Report:

The customer success report is based on over 1,400 pieces of verified customer reference content. A vendor’s overall customer success score is reached via a weighted average of their Content, Market Presence, and Company Scores. Of the vendors listed in the FeaturedCustomers’ Board Management Software category, 18 vendors met the minimum requirements needed to be considered for the customer success report.

About FeaturedCustomers:

FeaturedCustomers, the world’s only customer reference platform for B2B business software and services, helps potential B2B buyers research and discover business software and services through vendor validated customer reference content such as customer testimonials, success stories, case studies, and customer videos. Every day our platform helps influence the purchasing decisions of thousands of B2B buyers in the final stages of their buying cycle from Fortune 500 companies to SMB’s. For more information, visit their website.

Follow us and connect with us on LinkedIn.

Share article on social media or email:

[ad_2]

Home and Family: Marriage / Relationships

Eye of Love Partners With The Millionaire Matchmaker Patti Stanger For Matchmaker Pheromone Perfume

Leave a comment

[ad_1]

News Image

“It doesn’t matter if you’re married, single, straight or gay, it’s going to make you electrifying to the sex of your choice,” said Stanger.


SAN DIEGO (PRWEB)

The experts at Eye of Love, leaders of pheromone-infused perfumes worldwide, launch Matchmaker, a scent collection with matchmaker Patti Stanger in this season of love. Stanger is the star and executive producer of Bravo’s The Millionaire Matchmaker and the ultimate professional in assisting people in finding their perfect match.

Matchmaker features high-quality, high-potency pheromones that pleasantly awaken senses to make you feel good inside and out and attract those around you. The perfume arrives in luxurious packaging that holds a striking diamond glass bottle to simulate a wedding ring, appropriate for gift-giving and vanity displays.

The four scent options in the Matchmaker series include ever-so enticing formulas to attract her to him, him to her, him to him and her to her. The perfumes embody a sensual blend of jasmine, grapefruit, and amber with a touch of citrus plus a bold blend of cedar, blackcurrant and lemon.

It doesn’t matter if you’re married, single, straight or gay, it’s going to make you electrifying to the sex of your choice,” said Stanger. “We teamed up with Patti to create the perfect combination of pheromones and irresistible fragrances. Spray on the neckline for maximum impact and be prepared to love what happens next,” said Jacqui Rubinoff, Vice President of Eye of Love.

Eye of Love Pheromone Perfumes provide added benefits to our daily lives, all containing a long-lasting pheromone dose designed to boost self-confidence, encourage attraction and develop that extra compelling edge. The pheromone sends subconscious signals to others, triggering powerful social and romantic responses.

Eye of Love and Stanger will give away a 1-carat diamond ring to celebrate the launch, with a winner announced in summer 2022 (enter on https://www.eyeoflove.com).

For more information, visit http://www.eyeoflove.com.

About Eye of Love:

Eye of Love pheromone-infused perfumes are designed to help individuals attract one another and give an added edge to connections. As the leading pheromone-infused brand sold in over 20 countries, its mission is to spread love around the globe and enhance people’s daily lives with scents that bring out the best in you.

Share article on social media or email:

[ad_2]